Janssen Products, a subsidiary of Johnson & Johnson, has sued Indian pharmaceutical company Hetero Drugs for applying to market a generic version of its HIV treatment Prezista.
If you have already subscribed please login.
If you have any technical issues please email tech support.
Janssen, Tibotec, Johnson & Johnson, generic, Prezista, patent
